Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Maffrand

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Thrombosis Research|November 15, 1987
Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADPR Féliste, D Delebassée, M F Simon, et al.
Circulation|December 1, 1993
Combined ADP and thromboxane A2 antagonism prevents cyclic flow variations in stenosed and endothelium-injured arteries in nonhuman primatesS K Yao, J McNatt, K Cui, et al.
Biochemical Pharmacology|June 15, 1987
"Supersulfated" heparin fragments, a new type of low-molecular weight heparin. Physico-chemical and pharmacological propertiesA Naggi, G Torri, B Casu, et al.
Thrombosis and Haemostasis|April 12, 1990
Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in ratsM Freund, J P Cazenave, M Courtney, et al.
Thrombosis and Haemostasis|December 29, 2000
Identification and biological activity of the active metabolite of clopidogrelP Savi, J M Pereillo, M F Uzabiaga, et al.
Journal of Cellular Physiology|July 1, 1996
Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulatorsZ C Han, S Bellucci, Z X Shen, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1992
Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitorJ M Herbert, D Frehel, M P Rosso, et al.
Biochemical Pharmacology|February 11, 1994
Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cellsC Serradeil-Le Gal, B Bourrié, D Raufaste, et al.
British Journal of Pharmacology|January 12, 1999
In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileumT Croci, L Manara, G Aureggi, et al.
European Journal of Pharmacology|April 1, 1994
Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonistsM Azzi, D Gully, M Heaulme, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Thrombosis Research|November 15, 1987
Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADPR Féliste, D Delebassée, M F Simon, et al.
Circulation|December 1, 1993
Combined ADP and thromboxane A2 antagonism prevents cyclic flow variations in stenosed and endothelium-injured arteries in nonhuman primatesS K Yao, J McNatt, K Cui, et al.
Biochemical Pharmacology|June 15, 1987
"Supersulfated" heparin fragments, a new type of low-molecular weight heparin. Physico-chemical and pharmacological propertiesA Naggi, G Torri, B Casu, et al.
Thrombosis and Haemostasis|April 12, 1990
Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in ratsM Freund, J P Cazenave, M Courtney, et al.
Thrombosis and Haemostasis|December 29, 2000
Identification and biological activity of the active metabolite of clopidogrelP Savi, J M Pereillo, M F Uzabiaga, et al.
Journal of Cellular Physiology|July 1, 1996
Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulatorsZ C Han, S Bellucci, Z X Shen, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1992
Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitorJ M Herbert, D Frehel, M P Rosso, et al.
Biochemical Pharmacology|February 11, 1994
Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cellsC Serradeil-Le Gal, B Bourrié, D Raufaste, et al.
British Journal of Pharmacology|January 12, 1999
In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileumT Croci, L Manara, G Aureggi, et al.
European Journal of Pharmacology|April 1, 1994
Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonistsM Azzi, D Gully, M Heaulme, et al.
Pageof 12